2022 UNSW Cancer Seed Grant Recipients

Cancer Seed grant recipients

At the end of 2021, the UNSW Cancer Theme announced the successful applications to UNSW Cancer Seed grants submitted in response to a call in November 2021. These seed grants aim to facilitate new collaborations within UNSW and to support ideas led by early and mid-career researchers.

In total, 33 grant applications were received and reviewed by the Scientific Advisory Board, with many high quality ideas submitted it was with much difficulty the final five were shortlisted.

Congratulations to the following successful applications:

  • Dr Benjamin Daniels, Centre for Big Data Research - Understanding the impact of SARS-CoV-2 (COVID-19) on Australian cancer treatment. 
  • Dr Leila Eshraghi, Garvan - Elucidating the oncogenic role of telomere dysfunction in drug resistant ER+ breast cancer.
  • Dr Jackie Huang, CCI -  Sensitisation and eradication of chemo-resistant T-ALL by repurposing epigenetic and myeloid-directed drugs.
  • Dr Ernesto Moles, CCI -  In vivo controlled reprogramming of T cells with chimeric antigen receptor-encoding mRNA nanoparticles to potently suppress brain cancer.
  • Dr Brooke Pereira, Garvan - Repurposing PCSK9 inhibitor PF-846 to enhance immunotherapy in pancreatic cancer.

    UNSW Medicine Yammer


    Quick Links

    Medicine News

    Medicine Events

    VC Message

    2025 Strategy

    News @ UNSW